CareCloud (NASDAQ:CCLD) Updates FY 2025 Earnings Guidance

Key Points

• CareCloud has updated its FY 2025 earnings guidance, forecasting an EPS of 0.100-0.130 and revenue between $111.0 million-$114.0 million, slightly below consensus estimates.
• Despite a slight drop in stock price of 1.3%, CareCloud has received an upgraded rating from Wall Street Zen from "hold" to "buy."
• In institutional news, Acadian Asset Management increased its holdings in CareCloud by 481.9% in the first quarter, now owning approximately 0.48% of the company.

CareCloud (NASDAQ:CCLD - Get Free Report) updated its FY 2025 earnings guidance on Tuesday. The company provided EPS guidance of 0.100-0.130 for the period, compared to the consensus EPS estimate of 0.100. The company issued revenue guidance of $111.0 million-$114.0 million, compared to the consensus revenue estimate of $111.6 million.

Wall Street Analyst Weigh In

Several research analysts have weighed in on CCLD shares. Wall Street Zen upgraded CareCloud from a "hold" rating to a "buy" rating in a research note on Sunday, July 13th. Roth Capital reissued a "neutral" rating on shares of CareCloud in a research note on Tuesday, May 6th.

CareCloud Stock Down 1.3%

Shares of CareCloud stock traded down $0.03 during trading on Tuesday, hitting $2.35. 457,550 shares of the company were exchanged, compared to its average volume of 606,158. CareCloud has a fifty-two week low of $1.14 and a fifty-two week high of $4.84. The stock has a market capitalization of $99.45 million, a price-to-earnings ratio of -10.68 and a beta of 1.99. The firm has a 50 day moving average price of $2.32 and a 200 day moving average price of $2.34.

CareCloud (NASDAQ:CCLD - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.04). The firm had revenue of $27.60 million during the quarter, compared to the consensus estimate of $25.94 million. CareCloud had a return on equity of 24.08% and a net margin of 8.92%. Analysts predict that CareCloud will post 0.58 earnings per share for the current year.

Insider Buying and Selling

In other news, Director John N. Daly sold 15,000 shares of the stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $2.11, for a total transaction of $31,650.00. Following the transaction, the director owned 61,750 shares in the company, valued at $130,292.50. This represents a 19.54% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 14.70% of the company's stock.

Hedge Funds Weigh In On CareCloud

An institutional investor recently raised its position in CareCloud stock. Acadian Asset Management LLC raised its holdings in CareCloud, Inc. (NASDAQ:CCLD - Free Report) by 481.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 203,053 shares of the company's stock after purchasing an additional 168,156 shares during the period. Acadian Asset Management LLC owned approximately 0.48% of CareCloud worth $280,000 at the end of the most recent quarter. 10.16% of the stock is owned by institutional investors.

About CareCloud

CareCloud, Inc, a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.